Abstract
BACKGROUND: Proper pharmaceutical inventory management is critical in guiding decisions that mitigate cyclic stockouts. It sets purchasing priorities, informs the procurement of cost-effective drugs, and ensures that there is a balance between inventory expenditure and the demand for medications. This study aimed to evaluate the drug consumption and expenditure patterns at a leading referral hospital in Western Kenya, i.e., the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH). Drug consumption and expenditure data at JOOTRH were analyzed over 3 years (2018-2020) using Therapeutic Class (TC), Always Better Control (ABC), and Vital Essential and Non-essential (VEN) analysis. Data sources included the Kenya Health Information System (KHIS), bin cards, invoices, delivery notes, and patient files. RESULTS: The total pharmaceutical expenditure (TPE) over the study period was $1,329,213.91. The annual pharmaceutical expenditure (APE) was $389,158.51, $501,365.79, and $438,689.61 for 2018, 2019, and 2020, respectively. ABC analysis indicated that 53 (18.9%), 56 (19.9%), and 56 (19.9%) of items were Class A medicines in 2018, 2019, and 2020, respectively, and consumed 70.2%, 71.7%, and 72.7% of the APE in 2018, 2019, and 2020, respectively. VEN analysis revealed that 173 drugs were classified as vital items in each of the years 2018, 2019, and 2020, and consumed 77.7%, 75.1%, and 74.2% of the APE in 2018, 2019, and 2020, respectively. TC analysis indicated that anti-infectives were the most consumed class of medicine over the study period and consumed 27.4%, 23.5%, and 30.4% of the APE in 2018, 2019, and 2020, respectively. CONCLUSIONS: According to this analysis, Category I pharmaceuticals accounted for the majority of the total pharmaceutical expenditure at the hospital and require special attention for control.
Full text
621 characters
· extracted from
oa-doi-fallback
· click to expand
There is a newer version available for this {{ publicationType }}. View latest version
{{ publication.field_name }}
{{ publication.subfield_name }}
Copyright: © {{ publicationYear }} {{ publication.presentation_authors[0].full_name + (publication.presentation_authors.length > 1 ? ' et al' : '') }}. This is an open access publication distributed under the terms of the CC BY 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Check the {{ publicationType | capitalize }} Source for copyright and license information.
Listen on
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.